{"id":25194,"date":"2025-06-05T09:16:38","date_gmt":"2025-06-05T09:16:38","guid":{"rendered":"https:\/\/www.euforea.org\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/"},"modified":"2026-08-20T07:56:59","modified_gmt":"2026-08-20T07:56:59","slug":"asma-y-rsccpn-elevando-el-liston-con-la-remision","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/","title":{"rendered":"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"25194\" class=\"elementor elementor-25194 elementor-14672\" data-elementor-post-type=\"news\">\n\t\t\t\t<div class=\"elementor-element elementor-element-48a9837 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"48a9837\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-516a6b9 elementor-widget elementor-widget-euforea_general_content\" data-id=\"516a6b9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_content.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n    <div data-quickedit-entity-id=\"paragraph\/842\" class=\"paragraph paragraph--text-columns paragraph-id--842 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n      <div class=\"inner--wide\">\n        <div class=\"text__text text text--paragraph\">\n        \t          <p>La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN), lo que representa un cambio desde el objetivo tradicional del control de los s\u00edntomas hacia un est\u00e1ndar de atenci\u00f3n m\u00e1s ambicioso y exhaustivo. Durante a\u00f1os, el concepto de remisi\u00f3n se pas\u00f3 por alto en estas afecciones, a diferencia de muchas otras enfermedades cr\u00f3nicas. Ese paradigma est\u00e1 cambiando ahora. Los avances en el tratamiento \u2014incluidas las terapias dirigidas, los enfoques personalizados, las estrategias preventivas y la atenci\u00f3n multidisciplinar\u2014 est\u00e1n permitiendo a los cl\u00ednicos perseguir la remisi\u00f3n como un objetivo realista para los pacientes con asma grave y RSCcPN.   <\/p>\n<p>Para respaldar esta evoluci\u00f3n, EUFOREA ha publicado una declaraci\u00f3n de consenso que define la remisi\u00f3n tanto en el asma como en la RSCcPN. Esta iniciativa tiene como objetivo alinear el lenguaje utilizado por los profesionales sanitarios, al tiempo que ayuda a los pacientes a comprender mejor los objetivos de su tratamiento. La remisi\u00f3n ya no es solo un objetivo aspiracional, sino que se est\u00e1 convirtiendo r\u00e1pidamente en el \u00absanto grial\u00bb de la atenci\u00f3n respiratoria moderna.  <\/p>\n<p>En este episodio, EUFOREA invita a la <strong>profesora Yvonne Chan<\/strong>, otorrinolaring\u00f3loga jefa en el St. Michael's Hospital de Toronto y profesora asociada en el Departamento de Otorrinolaringolog\u00eda - Cirug\u00eda de Cabeza y Cuello de la Universidad de Toronto, y al <strong>profesor Michael Wechsler<\/strong>, profesor de Medicina en el hospital National Jewish Health de Denver, Colorado, Estados Unidos, y director del NJH Cohen Family Asthma Institute en la Divisi\u00f3n de Medicina Pulmonar, Cuidados Cr\u00edticos y del Sue\u00f1o.<\/p>\n        <\/div>\n      <\/div>\n    <\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-15ce672 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"15ce672\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ede88f3 elementor-widget elementor-widget-video\" data-id=\"ede88f3\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/youtu.be\\\/lg-yxTr36rg&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN), lo que representa un cambio desde el objetivo tradicional del control de los s\u00edntomas hacia un est\u00e1ndar de atenci\u00f3n m\u00e1s ambicioso y exhaustivo. Durante a\u00f1os, el concepto de remisi\u00f3n se pas\u00f3 por alto en estas afecciones, a diferencia de muchas otras enfermedades cr\u00f3nicas. Ese paradigma est\u00e1 cambiando ahora. Los avances en el tratamiento \u2014incluidas las terapias dirigidas, los enfoques personalizados, las estrategias preventivas y la atenci\u00f3n multidisciplinar\u2014 est\u00e1n permitiendo a los cl\u00ednicos perseguir la remisi\u00f3n como un objetivo realista para los pacientes con asma grave y RSCcPN. Para respaldar esta evoluci\u00f3n, EUFOREA ha publicado una declaraci\u00f3n de consenso que define la remisi\u00f3n tanto en el asma como en la RSCcPN. Esta iniciativa tiene como objetivo alinear el lenguaje utilizado por los profesionales sanitarios, al tiempo que ayuda a los pacientes a comprender mejor los objetivos de su tratamiento. La remisi\u00f3n ya no es solo un objetivo aspiracional, sino que se est\u00e1 convirtiendo r\u00e1pidamente en el \u00absanto grial\u00bb de la atenci\u00f3n respiratoria moderna. En este episodio, EUFOREA invita a la profesora Yvonne Chan, otorrinolaring\u00f3loga jefa en el St. Michael&#8217;s Hospital de Toronto y profesora asociada en el Departamento de Otorrinolaringolog\u00eda &#8211; Cirug\u00eda de Cabeza y Cuello de la Universidad de Toronto, y al profesor Michael Wechsler, profesor de Medicina en el hospital National Jewish Health de Denver, Colorado, Estados Unidos, y director del NJH Cohen Family Asthma Institute en la Divisi\u00f3n de Medicina Pulmonar, Cuidados Cr\u00edticos y del Sue\u00f1o.<\/p>\n","protected":false},"author":9,"featured_media":25196,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[166],"tags":[],"class_list":["post-25194","news","type-news","status-publish","has-post-thumbnail","hentry","category-programas-de-noticias-de-euforea"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n - EUFOREA<\/title>\n<meta name=\"description\" content=\"La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n\" \/>\n<meta property=\"og:description\" content=\"La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T07:56:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1748\" \/>\n\t<meta property=\"og:image:height\" content=\"1015\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/\",\"name\":\"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/remission-in-asthma-and-crswnp-teaser.jpg\",\"datePublished\":\"2025-06-05T09:16:38+00:00\",\"dateModified\":\"2026-08-20T07:56:59+00:00\",\"description\":\"La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/remission-in-asthma-and-crswnp-teaser.jpg\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/remission-in-asthma-and-crswnp-teaser.jpg\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/asma-y-rsccpn-elevando-el-liston-con-la-remision\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/elige-tu-camino\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n - EUFOREA","description":"La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/","og_locale":"es_ES","og_type":"article","og_title":"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n","og_description":"La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN).","og_url":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","article_modified_time":"2026-08-20T07:56:59+00:00","og_image":[{"width":1748,"height":1015,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/","url":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/","name":"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","datePublished":"2025-06-05T09:16:38+00:00","dateModified":"2026-08-20T07:56:59+00:00","description":"La remisi\u00f3n ha surgido como el nuevo referente en el tratamiento tanto del asma como de la rinosinusitis cr\u00f3nica con p\u00f3lipos nasales (RSCcPN).","breadcrumb":{"@id":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/remission-in-asthma-and-crswnp-teaser.jpg","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/es\/news\/asma-y-rsccpn-elevando-el-liston-con-la-remision\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.euforea.org\/es\/elige-tu-camino\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Asma y RSCcPN: Elevando el List\u00f3n con la Remisi\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/25194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/comments?post=25194"}],"version-history":[{"count":1,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/25194\/revisions"}],"predecessor-version":[{"id":25197,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/25194\/revisions\/25197"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media\/25196"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media?parent=25194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/categories?post=25194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/tags?post=25194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}